Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,371 across all filing types
Latest filing 2025-09-29 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
INTERIM REPORT 2025
Interim / Quarterly Report Classification · 1% confidence The document is explicitly titled '2025 Interim Report' and '中期報告' (Interim Report). It contains comprehensive financial statements, including the 'Condensed Consolidated Statement of Profit or Loss', 'Condensed Consolidated Statement of Financial Position', and 'Notes to the Condensed Consolidated Financial Statements', as well as a 'Management Discussion and Analysis' section. It covers the six-month period ended June 30, 2025, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-29 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT ENROLLMENT IN GLOBAL PHASE II TRIAL OF CS2009 (PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY) IN AUSTRALIA
Regulatory Filings
2025-09-23 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Governance Information Classification · 1% confidence The document provides a structured list of the company’s board members, their roles (executive, non-executive, independent), and committee memberships—detailing the board structure and governance framework. It is not announcing changes to management nor is it soliciting votes; rather, it outlines the company’s governance arrangements. This matches the definition of a Governance Information report (CGR).
2025-09-23 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 1% confidence The document is a Hong Kong stock exchange announcement detailing the appointment of a new independent non-executive director, including biographical details, terms of appointment, committee memberships, and compliance with listing rule requirements. This clearly fits the category of a board/management change announcement rather than a full report, earnings release, or other filing type.
2025-09-23 English
INSIDE INFORMATION PROPOSED SPIN-OFF OF KASONG SCIENCE AND TECHNOLOGY AND QUOTATION OF ITS SHARES ON NATIONAL EQUITIES EXCHANGE AND QUOTATIONS
Regulatory Filings Classification · 1% confidence The document is an "Inside Information" announcement under the Hong Kong Listing Rules regarding the proposed spin-off of a subsidiary and quotation of its shares on NEEQ. It does not present full financial statements (so not an Annual or Interim Report), nor is it an earnings release, AGM materials, proxy statement, management or audit report, nor is it a capital raising or M&A takeover. It is a regulatory announcement of a corporate restructuring/inside information and thus falls into the fallback category of a general regulatory filing.
2025-09-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-09-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.